Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity
abacavir
CNA106030
NCT00340080
Infection, Human Immunodeficiency Virus
Phase 4
 
January 2014

Powered by ideaPoint, Inc.